Core Scientific (CORZ) Change in Account Payables (2021 - 2026)

Core Scientific has reported Change in Account Payables for 6 years, with the latest figure at -$41.5 million in Q2 2026.

• Quarterly Change in Account Payables fell 128.05% year-over-year to -$41.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$158.3 million (down 219.29% YoY) and the FY2025 annual result came in at $10.8 million, up 187.86% from the prior year.
• Change in Account Payables fell to -$41.5 million in Q2 2026 per CORZ's latest filing, from $5.9 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $147.8 million in Q2 2025 and troughed at -$151.1 million in Q3 2025.
• A 5-year average of $6.0 million and a median of $2.9 million in 2024 frame the typical range for Change in Account Payables.
• The widest YoY moves for Change in Account Payables: up 8571.4% in 2025, down 94368.12% in 2025.
• Over 5 years, Change in Account Payables stood at $23.8 million in 2022, then surged by 262.56% to $86.1 million in 2023, then slumped by 100.73% to -$632000.0 in 2024, then jumped by 4593.67% to $28.4 million in 2025, then plunged by 246.01% to -$41.5 million in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$41.5 million, $5.9 million, and $28.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.